Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Jenkins

Showing results (91-100 of 269) with videos related to

Pageof 27
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 20, 2007
MGMT immunohistochemical expression and promoter methylation in human glioblastomaFausto J Rodriguez, Stephen N Thibodeau, Robert B Jenkins, et al.
BJU International|March 13, 2015
Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrenceMohammed Alshalalfa, Anamaria Crisan, Ismael A Vergara, et al.
Cancer Research|October 19, 2006
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendrogliomaRobert B Jenkins, Hilary Blair, Karla V Ballman, et al.
Clinical Genitourinary Cancer|January 17, 2017
Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate CancerJennifer M Lobo, Daniel M Trifiletti, Vanessa N Sturz, et al.
Genes, Chromosomes & Cancer|July 21, 2005
Prevalence of 9p21 deletions in UK melanoma familiesSushila H Mistry, Claire Taylor, Juliette A Randerson-Moor, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 8, 2011
MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumorsAatur D Singhi, Ashley Cimino-Mathews, Robert B Jenkins, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular SubtypesTaishi Nakase, Geno Guerra, Quinn T Ostrom, et al.
Cancer|December 20, 2002
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriersCamilo Adem, Carol Reynolds, Cheryl L Soderberg, et al.
Neuro-Oncology Advances|November 18, 2020
Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomasMatthew K Ball, Thomas M Kollmeyer, Corinne E Praska, et al.
Medical Epigenetics|August 4, 2015
Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosisAbdirashid Shire, Gwen Lomberk, Jin-Ping Lai, et al.
Pageof 27

Showing results (91-100 of 269) with videos related to

Sort By:
Pageof 27
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 20, 2007
MGMT immunohistochemical expression and promoter methylation in human glioblastomaFausto J Rodriguez, Stephen N Thibodeau, Robert B Jenkins, et al.
BJU International|March 13, 2015
Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrenceMohammed Alshalalfa, Anamaria Crisan, Ismael A Vergara, et al.
Cancer Research|October 19, 2006
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendrogliomaRobert B Jenkins, Hilary Blair, Karla V Ballman, et al.
Clinical Genitourinary Cancer|January 17, 2017
Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate CancerJennifer M Lobo, Daniel M Trifiletti, Vanessa N Sturz, et al.
Genes, Chromosomes & Cancer|July 21, 2005
Prevalence of 9p21 deletions in UK melanoma familiesSushila H Mistry, Claire Taylor, Juliette A Randerson-Moor, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 8, 2011
MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumorsAatur D Singhi, Ashley Cimino-Mathews, Robert B Jenkins, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular SubtypesTaishi Nakase, Geno Guerra, Quinn T Ostrom, et al.
Cancer|December 20, 2002
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriersCamilo Adem, Carol Reynolds, Cheryl L Soderberg, et al.
Neuro-Oncology Advances|November 18, 2020
Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomasMatthew K Ball, Thomas M Kollmeyer, Corinne E Praska, et al.
Medical Epigenetics|August 4, 2015
Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosisAbdirashid Shire, Gwen Lomberk, Jin-Ping Lai, et al.
Pageof 27